Bretylium tosilate

Bretylium Tosylate Inj 50MG/ML

50 MG / ML SolutionCanadaCancelledAuthorised 31 Dec 1991

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Bretylium TosylateUnited States · 100MG/ML, 50MG/ML, 50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable · Abraxis PharmSame substance
BretylolUnited States · 50MG/ML · injectable · HospiraSame substance
Bretylium Tosylate in Dextrose 5%United States · 200MG/100ML, 400MG/100ML, 800MG/100ML · injectable · AbbottSame substance

Documents

The official texts, at the regulator.

Register entryHealth Canada

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Bretylium tosilate

Bretylium Tosylate Inj 50MG/ML

50 MG / ML SolutionCanadaCancelledAuthorised 31 Dec 1991

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Register entryHealth Canada

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Bretylium tosilate
Strength: 50 MG / ML
Dosage form: Solution
Route: Intramuscular, Intravenous
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 31 Dec 1991
Registration: DIN 00786594
Marketing authorisation holder: Abbott Laboratories, Limited
ATC code: C01BD02
Group: Cardiovascular system
Supply: PRESCRIPTION

Cancelled